$DCBO

Docebo Inc.

Insider trades
1
0
0

No SEC Form 4 filings for $DCBO in the last 30 days.

See all $DCBO insider activity →
Med

Docebo at Oppenheimer conference: enterprise push lifts outlook

Docebo (DCBO) discussed its shift from a learning management system to a hybrid learning and skills platform at the Oppenheimer tech conference. The company said first-half 2026 results beat guidance, with 2026 EBITDA margin guided at 20% and midterm around 27%. It expects easier comparisons to support second-half ARR growth and highlighted enterprise, government, healthcare, and AI monetization timing.

15 Stocks Beating Wall Street’s Earnings Expectations

FactSet says about 75% of S&P 500 companies reported Q2 results, with 85% beating analyst expectations. It estimates S&P 500 earnings up 50.4% year over year and revenue up about 15%, versus 12.2% expected. The article lists multiple stocks with EPS above consensus, including ESNT, FLR, TILE, and UAA.

TSX Finds Upward Progress

Monday, Canada’s TSX rose 77.1 points to 36,458.33, led by energy. The Canadian dollar edged up to 71.74 U.S. cents. Barrick missed Q2 profit estimates, shares down 6.5% to $57.03. Strathcona Energy and IPCO gained. TSX Venture rose 2% to 973.81. Oil rose to $82.06 and gold to $4,451.70/oz amid Middle East ceasefire hopes.

DCBO sentiment & insider activity

Over the past 7 days, alphai's AI scored 1 news story mentioning DCBO (Docebo Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.

Recent DCBO coverage spans financial news, corporate actions and technology.

What's driving DCBO

  • Conference commentary provides fresh, decision-relevant guidance and margin targets, with a clear enterprise and AI monetization timeline.

    investing.com · Aug 13, 2026

  • A beat versus consensus can improve sentiment for growth software names, but the article lacks forward metrics.

    insidermonkey.com · Aug 11, 2026

  • DCBO’s move is framed as part of the broader market bid, not a standalone disclosure.

    baystreet.ca · Aug 10, 2026

  • The commencement of the issuer bid is a direct capital return catalyst that can support near-term sentiment and reduce share count over time.

    thestarphoenix.com · Jul 21, 2026

  • The issuer bid plus preliminary growth metrics can support near-term sentiment, but the credit-facility funding and upcoming Aug 7 full results create event risk.

    leaderpost.com · Jul 17, 2026

alphai scores every news story that mentions DCBO with an AI model for sentiment and relevance, and aggregates insider trades from Docebo Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $DCBO

Score
$DCBOMed

Docebo at Oppenheimer conference: enterprise push lifts outlook

Docebo (DCBO) discussed its shift from a learning management system to a hybrid learning and skills platform at the Oppenheimer tech conference. The company said first-half 2026 results beat guidance, with 2026 EBITDA margin guided at 20% and midterm around 27%. It expects easier comparisons to support second-half ARR growth and highlighted enterprise, government, healthcare, and AI monetization timing.

15 Stocks Beating Wall Street’s Earnings Expectations

FactSet says about 75% of S&P 500 companies reported Q2 results, with 85% beating analyst expectations. It estimates S&P 500 earnings up 50.4% year over year and revenue up about 15%, versus 12.2% expected. The article lists multiple stocks with EPS above consensus, including ESNT, FLR, TILE, and UAA.

$SVMMed

TSX Finds Upward Progress

Monday, Canada’s TSX rose 77.1 points to 36,458.33, led by energy. The Canadian dollar edged up to 71.74 U.S. cents. Barrick missed Q2 profit estimates, shares down 6.5% to $57.03. Strathcona Energy and IPCO gained. TSX Venture rose 2% to 973.81. Oil rose to $82.06 and gold to $4,451.70/oz amid Middle East ceasefire hopes.

$DCBOMedAI 8/10

Docebo Inc. Announces Substantial Issuer Bid, Preliminary Unaudited Second Quarter 2026 Financial Results, Initial Q3-2026 and Revised FY2026 Guidance

Docebo Inc. (NASDAQ: DCBO, TSX: DCBO) said its board approved a substantial issuer bid to repurchase up to US$70m of common shares at US$20.40 each, funded by about US$10m cash and a US$60m credit-facility draw. Preliminary Q2 2026 results: subscription revenue US$63.5-63.7m, total revenue US$68.3-68.5m, adjusted EBITDA US$10.9-11.1m. Full results due Aug 7, 2026.

Did Docebo’s (TSX:DCBO) New AI Learning Hub and Guidance Hike Just Redefine Its Investment Narrative?

Docebo Inc. recently unveiled a next-generation AI-driven learning platform at Docebo Inspire 2026 and raised its 2026 revenue guidance to US$271.0 million–US$275.0 million, attributing over 50% of recent new product releases to AI-assisted development. While the product-led growth is a near-term catalyst and projected revenue by 2029 is $331.1 million, investors should remain aware of potential risks such as macro-sensitive sales cycles, intense competition, and the uncertain monetization of advanced AI features. The company's integration of its content into popular AI assistants like Microsoft Copilot and ChatGPT could drive adoption but also exposes it to rapid AI commoditization and pricing pressure.

$DCBOMed

Docebo Inc (DCBO) Shares Fall 8.5% -- What GF Score of 70 Tells Investors

Docebo Inc (DCBO) shares dropped 8.5% to $14.70, marking a significant 33.8% year-to-date decline and nearly 50% over the past year. Despite its GF Score™ of 70/100, indicating an "Above Average" potential for long-term returns, the stock is considered significantly undervalued with a GF Value™ of $59.61. Investors are advised to consider the company's strong financial health and growth prospects against its current weak profitability and momentum.

Related tickers